Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  27,804 results for ""Rimonabant""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Acute rimonabant treatment prevents anhedonia and memory loss in rats submitted to mild restraint stress.

  • Authors : Chagas LA; Graduate Program in Biosciences applied to Health, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil.; Penna J

Subjects: Rimonabant*/Rimonabant*/Rimonabant*/pharmacology ; Stress, Psychological*/Stress, Psychological*/Stress, Psychological*/metabolism ; Rats, Wistar*

  • Source: Behavioural brain research [Behav Brain Res] 2024 Oct 02; Vol. 474, pp. 115175. Date of Electronic Publication: 2024 Aug 06.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile.

  • Authors : Cohen Y; Corbus Pharmaceuticals Holdings Inc., Norwood, Massachusetts, USA.; Kolodziej A

Subjects: Rimonabant* ; United States Food and Drug Administration* ; Anti-Obesity Agents*/Anti-Obesity Agents*/Anti-Obesity Agents*/adverse effects

  • Source: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2024 Jul; Vol. 32 (7), pp. 1235-1244. Date of Electronic Publication: 2024 Jun 17.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome.

  • Authors : Cosentino L; Center for Behavioral Sciences and Mental Health, Italian National Institute of Health, Rome, Italy.; Urbinati C

Subjects: Brain*/Brain*/Brain*/metabolism ; Brain*/Brain*/Brain*/drug effects ; Disease Models, Animal*

  • Source: Molecular autism [Mol Autism] 2024 Sep 19; Vol. 15 (1), pp. 39. Date of Electronic Publication: 2024 Sep 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101534222 Publication Model: Electronic Cited Medium: Internet ISSN: 2040-2392

Record details

Read More Add to Saved list
×
Academic Journal

Behavioral assessment of rimonabant under acute and chronic conditions.

  • Authors : Ettaro R; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.; Laudermilk L

Subjects: Social Behavior*; Behavior, Animal/Behavior, Animal/Behavior, Animal/*drug effects ; Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/*pharmacology

  • Source: Behavioural brain research [Behav Brain Res] 2020 Jul 15; Vol. 390, pp. 112697. Date of Electronic Publication: 2020 May 15.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Chlorotrimethylsilane promoted one-flask heterocyclic synthesis of 1,2,4-triazoles from nitrilimines: Modeling studies and bioactivity evaluation of LH-21 and Rimonabant analogues.

  • Authors : Tsai SE; School of Pharmacy, China Medical University, No. 91, Hsueh-Shih Rd., Taichung 40402, Taiwan; Ph.D. Program for Biotech Pharmaceutical Industry, China Medical University, No. 91, Hsueh-Shih Rd., Taichung 40402, Taiwan.

Subjects: Heterocyclic Compounds/Heterocyclic Compounds/Heterocyclic Compounds/*chemical synthesis ; Imines/Imines/Imines/*chemistry ; Rimonabant/Rimonabant/Rimonabant/*chemical synthesis

  • Source: Bioorganic chemistry [Bioorg Chem] 2020 Nov; Vol. 104, pp. 104299. Date of Electronic Publication: 2020 Sep 21.Publisher: Elsevier Country of Publication: United States NLM ID: 1303703 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Synthesis of 1-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-2-morpholinoethane-1,2-dione analogues and their inhibitory activities with reduced cytotoxicity in lipopolysaccharide-induced BV2 cells.

  • Authors : Yoon SH; Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.; Cho DY

Subjects: Anti-Inflammatory Agents*/Anti-Inflammatory Agents*/Anti-Inflammatory Agents*/pharmacology ; Lipopolysaccharides*/Lipopolysaccharides*/Lipopolysaccharides*/pharmacology ; Rimonabant*/Rimonabant*/Rimonabant*/analogs & derivatives

  • Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Jan 01; Vol. 79, pp. 129061. Date of Electronic Publication: 2022 Nov 09.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways.

  • Authors : Rezq S; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Egypt. Electronic address: .; Hassan R

Subjects: Autophagy/Autophagy/Autophagy/*drug effects ; Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/*pharmacology ; Extracellular Signal-Regulated MAP Kinases/Extracellular Signal-Regulated MAP Kinases/Extracellular Signal-Regulated MAP Kinases/*metabolism

  • Source: International immunopharmacology [Int Immunopharmacol] 2021 Nov; Vol. 100, pp. 108140. Date of Electronic Publication: 2021 Sep 15.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.

  • Authors : Soler-Cedeno O; Addiction Biology Unit, Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA.; Xi ZX

Subjects: Receptor, Cannabinoid, CB1*/Receptor, Cannabinoid, CB1*/Receptor, Cannabinoid, CB1*/antagonists & inhibitors ; Rimonabant*/Rimonabant*/Rimonabant*/therapeutic use ; Substance-Related Disorders*/Substance-Related Disorders*/Substance-Related Disorders*/drug therapy

  • Source: Cells [Cells] 2022 Oct 17; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read More Add to Saved list
×
Academic Journal

Acute rimonabant treatment promotes protein synthesis in C2C12 myotubes through a CB1-independent mechanism.

  • Authors : Le Bacquer O; Université Clermont Auvergne, INRAE, Unité de Nutrition Humaine (UNH), Clermont-Ferrand, France.; Lanchais K

Subjects: Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/Cannabinoid Receptor Antagonists/*pharmacology ; Muscle Fibers, Skeletal/Muscle Fibers, Skeletal/Muscle Fibers, Skeletal/*drug effects ; Protein Biosynthesis/Protein Biosynthesis/Protein Biosynthesis/*drug effects

  • Source: Journal of cellular physiology [J Cell Physiol] 2021 Apr; Vol. 236 (4), pp. 2669-2683. Date of Electronic Publication: 2020 Sep 03.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0050222 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats.

  • Authors : Zhao L; Shanxi Medical University, No. 56, Xijian South Road, Taiyuan, 030001, Shanxi, People's Republic of China.; Liu T

Subjects: Hypoxia/Hypoxia/Hypoxia/*complications ; Mitochondria/Mitochondria/Mitochondria/*metabolism ; Receptor, Cannabinoid, CB1/Receptor, Cannabinoid, CB1/Receptor, Cannabinoid, CB1/*antagonists & inhibitors

  • Source: BMC nephrology [BMC Nephrol] 2021 Apr 26; Vol. 22 (1), pp. 153. Date of Electronic Publication: 2021 Apr 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369

Record details

Read More Add to Saved list
×
  • 1-10 of  27,804 results for ""Rimonabant""